Praxis Precision Medicines | S-3ASR:“知名成熟發行人”證券註冊聲明
Praxis Precision Medicines | 4:持股變動聲明-高管 Mastrocola Lauren
Praxis Precision Medicines | 4:持股變動聲明-高管 Kelly Timothy Edwin
Praxis Precision Medicines | 4:持股變動聲明-高管 Nemiroff Alex
Praxis Precision Medicines | 4:持股變動聲明-高管 Mastrocola Lauren
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-Steven A. Cohen(9.6%),Point72 Asset Management, L.P.(9.3%)等
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(5.0%),VHCP Co-Investment Holdings III, LLC(5.0%)等
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(4.3%),Peter Kolchinsky(4.3%)等
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-Cormorant Asset Management, LP(4.67%),Bihua Chen(4.67%)
Praxis Precision Medicines | 144:擬議出售證券
Praxis Precision Medicines | 144:擬議出售證券
Praxis Precision Medicines | SC 13G:超過5%持股股東披露文件-T. ROWE PRICE ASSOCIATES, INC.(6.3%)
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-Verition Fund Management LLC(1.8%),Nicholas Maounis(1.8%)
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.85%)
Praxis Precision Medicines | SC 13G:超過5%持股股東披露文件-Capital Research Global Investors(5.6%)
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-Adage Capital Management, L.P.(4.81%),Robert Atchinson(4.81%)等
Praxis Precision Medicines | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(7.3%)
Praxis Precision Medicines | 10-Q:2024財年三季報
Praxis Precision Medicines | 8-K:Praxis Precision Medicines提供公司最新情況並報告2024年第三季度財務業績
Praxis Precision Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.85%)